TrialOncology2024

Impact of Tumor Shrinkage Pattern with Biweekly Triplet Gemcitabine+Cisplatin+S-1 Regimen for Biliary Tract Cancers: Implications for Neoadjuvant Therapy from the Data of KHBO1401 (KHBO1401-1A Study).

Shogo Kobayashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.